Background: A prospective study was conducted to test the hypothesis t
hat cocaine use is a risk factor for neuroleptic-induced acute dystoni
a (NIAD). Method: The study sample consisted of a highrisk group for N
IAD, males aged 17-45 years who had received high-potency neuroleptics
within 24 hours of admission and had not used neuroleptics in the mon
th prior to admission. Patients were excluded if they suffered from a
neurodegenerative disorder or were exposed to anticholinergics, benzod
iazepines, promethazine, carbamazepine, phenytoin, or levodopa during
the study. Twenty-nine patients-9 cocaine users and 20 nonusers-entere
d the study, which lasted 2 years. Patients were followed for 7 days.
Results: Cocaine-using psychiatric patients developed significantly mo
re NIAD than did nonusers (relative risk = 4.4, 95% CI = 1.4 to 13.9).
Conclusion: Cocaine use is a major risk factor for NIAD and should be
added to the list of well-known risk factors. The authors strongly su
ggest that cocaine-using psychiatric patients who are started on a reg
imen of neuroleptics should also be administered an anticholinergic fo
r at least 7 days to prevent NIAD.